We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUTX
1601
Nutex Health
NUTX
$1.03B
$1.24M ﹤0.01%
39,211
-30,345
-44% -$865K
FWRD icon
1602
Forward Air
FWRD
$467M
$1.24M ﹤0.01%
+38,519
New +$1.34M
GDOT icon
1603
Green Dot
GDOT
$758M
$1.24M ﹤0.01%
116,709
-231,118
-66% -$2.55M
VRSK icon
1604
Verisk Analytics
VRSK
$27.8B
$1.24M ﹤0.01%
4,507
-207,918
-98% -$57.9M
MOG.A icon
1605
Moog Inc Class A
MOG.A
$13.1B
$1.24M ﹤0.01%
+6,301
New +$1.29M
GEN icon
1606
Gen Digital
GEN
$16.6B
$1.24M ﹤0.01%
+45,233
New +$1.3M
PRI icon
1607
Primerica
PRI
$10B
$1.23M ﹤0.01%
+4,531
New +$1.28M
CTV
1608
DELISTED
Innovid Corp.
CTV
$1.23M ﹤0.01%
+397,940
New +$939K
PPH icon
1609
VanEck Pharmaceutical ETF
PPH
$987M
$1.23M ﹤0.01%
14,232
+11,111
+356% +$1.01M
WWW icon
1610
Wolverine World Wide
WWW
$1.71B
$1.23M ﹤0.01%
55,304
-137,292
-71% -$2.76M
RYAM icon
1611
Rayonier Advanced Materials
RYAM
$591M
$1.23M ﹤0.01%
+148,612
New +$1.25M
LXFR icon
1612
Luxfer Holdings
LXFR
$456M
$1.22M ﹤0.01%
93,440
+44,431
+91% +$607K
SAND
1613
DELISTED
Sandstorm Gold
SAND
$1.22M ﹤0.01%
219,100
+180,428
+467% +$1.05M
WRLD icon
1614
World Acceptance Corp
WRLD
$880M
$1.22M ﹤0.01%
10,871
+5,980
+122% +$698K
MSGS icon
1615
Madison Square Garden
MSGS
$9.58B
$1.22M ﹤0.01%
5,410
-838
-13% -$187K
RMTI icon
1616
Rockwell Medical
RMTI
$27.6M
$1.22M ﹤0.01%
59,636
+8,769
+17% +$256K
TILE icon
1617
Interface
TILE
$2B
$1.21M ﹤0.01%
49,866
+7,167
+17% +$165K
MATX icon
1618
Matsons
MATX
$6.15B
$1.21M ﹤0.01%
8,999
-27,869
-76% -$4.06M
UFCS icon
1619
United Fire Group
UFCS
$1.35B
$1.21M ﹤0.01%
42,591
-13,237
-24% -$334K
XLB icon
1620
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.82B
$1.21M ﹤0.01%
+28,800
New +$1.33M
SWBI icon
1621
Smith & Wesson
SWBI
$657M
$1.21M ﹤0.01%
119,623
-206,881
-63% -$2.59M
FNGS icon
1622
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$543M
$1.21M ﹤0.01%
21,029
+11,275
+116% +$606K
JANX icon
1623
Janux Therapeutics
JANX
$915M
$1.2M ﹤0.01%
22,348
-25,703
-53% -$1.36M
BJRI icon
1624
BJ's Restaurants
BJRI
$1.45B
$1.2M ﹤0.01%
+34,055
New +$1.21M
FLEX icon
1625
Flex
FLEX
$41.5B
$1.19M ﹤0.01%
30,933
-478,814
-94% -$17.7M

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.